Proteomics Market to reach USD 96.35 Billion by 2032, growing at a CAGR of 13.61%
The proteomics market, centered on analyzing protein structures and functions, is growing rapidly due to technological innovations and rising demand from the healthcare, biotech, and pharmaceutical industries. Advances in mass spectrometry, protein separation, and bioinformatics have greatly improved protein analysis, supporting the expansion of personalized medicine. Proteomics is now essential for detecting disease biomarkers, enabling earlier diagnosis and customized treatment for conditions like cancer, cardiovascular diseases, and neurodegenerative disorders.